Rituximab for the treatment of autoimmune cytopenias by Sigbjørn Berentsen

Get full text

Sutimlimab for the Treatment of Cold Agglutinin Disease by Sigbjørn Berentsen

Get full text

Time for newer approach in age-old AIHA: Daratumumab? by Sigbjørn Berentsen, Suvro Sankha Datta

Get full text

Development of Multiple Myeloma of the IgA Type in a Patient with Cold Agglutinin Disease: Transformation or Coincidence? by Øystein Sefland, Ulla Randen, Sigbjørn Berentsen

Get full text

The choice of new treatments in autoimmune hemolytic anemia: how to pick from the basket? by Sigbjørn Berentsen, Bruno Fattizzo, Wilma Barcellini

Get full text

Editorial: Practical recommendations and consensus for the management of immune mediated hematologic diseases by Bruno Fattizzo, Bruno Fattizzo, Sigbjorn Berentsen, Wilma Barcellini

Get full text

Cold Agglutinin Disease: Improved Understanding of Pathogenesis Helps Define Targets for Therapy by Sigbjørn Berentsen, Shirley D’Sa, Ulla Randen, Agnieszka Małecka, Josephine M. I. Vos

Get full text

Paroxysmal cold hemoglobinuria successfully treated with complement inhibition by Sarah A. Lau-Braunhut, Hannah Stone, Griffin Collins, Sigbjørn Berentsen, Benjamin S. Braun, Matt S. Zinter

Get full text

Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma by Ulla Randen, Gunhild Trøen, Anne Tierens, Chloé Steen, Abdirashid Warsame, Klaus Beiske, Geir E. Tjønnfjord, Sigbjørn Berentsen, Jan Delabie

Get full text

Occurrence, thromboembolic risk, and mortality in Danish patients with cold agglutinin disease by Lauren C. Bylsma, Anne Gulbech Ording, Adam Rosenthal, Buket Öztürk, Jon P. Fryzek, Jaime Morales Arias, Alexander Röth, Sigbjørn Berentsen

Get full text

Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity by Agnieszka Małecka, Gunhild Trøen, Anne Tierens, Ingunn Østlie, Jędrzej Małecki, Ulla Randen, Sigbjørn Berentsen, Geir E. Tjønnfjord, Jan M.A. Delabie

Get full text

Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results by Alexander Roth, Wilma Barcellini, Shirley D’Sa, Yoshitaka Miyakawa, Catherine M. Broome, Marc Michel, David J. Kuter, Bernd Jilma, Tor Henrik Anderson Tvedt, Ilene C. Weitz, Parija Patel, Xiaoyu Jiang, Caroline Reuter, Jun Su, Frank Shafer, Michelle Lee, Sigbjorn Berentsen

Get full text

P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY by Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’sa, Bernd Jilma, Marc Michel, Ilene C Weitz, Masaki Yamaguchi, Jun-Ichi Nishimura, Josephine Vos, Joan Cid, Michael Storek, Nancy Wong, Ronnie Yoo, Deepthi Jayawardene, Shruti Srivastava, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M Broome

Get full text

P1469: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK OFF-TREATMENT PERIOD (WASHOUT) IN THE PHASE 3 CADENZA S... by Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’sa, Bernd Jilma, Marc Michel, Ilene C Weitz, Masaki Yamaguchi, Jun-Ichi Nishimura, Josephine Vos, Joan Cid, Michael Storek, Nancy Wong, Ronnie Yoo, Deepthi Jayawardene, Katarina Kralova, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M Broome

Get full text

Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part BResearch in context by Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, Bernd Jilma, Marc Michel, Ilene C. Weitz, Masaki Yamaguchi, Jun-ichi Nishimura, Josephine M.I. Vos, Joan Cid, Michael Storek, Nancy Wong, Ronnie Yoo, Deepthi Jayawardene, Shruti Srivastava, Marek Wardęcki, Frank Shafer, Michelle Lee, Catherine M. Broome

Get full text